Literature DB >> 15155372

Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data.

P R J Ames1, A Margarita, K B Sokoll, M Weston, V Brancaccio.   

Abstract

OBJECTIVE: To investigate the atherosclerosis hypothesis in primary antiphospholipid syndrome (PAPS).
METHODS: The intima media thickness (IMT) of carotid arteries and other cardiovascular risk factors was measured in 20 patients with PAPS (mean (SD) age 35 (12) years) and in 20 controls matched for age and sex (34 (12) years).
RESULTS: The frequency of smoking, hypertension, and dyslipidaemia was similar in the two groups, but plasma homocysteine was higher in patients with PAPS (mean (SD) 11.9 (6.2) v 8.2 (3.4) micromol/l, p = 0.037). The IMT was slightly greater in patients with PAPS than in controls at the carotid bifurcation (mean (SD) 0.61 (0.24) v 0.48 (0.09) mm, p = 0.04) and internal carotid artery (0.52 (0.22) v 0.40 (0.08), p = 0.01). These differences were more evident in patients aged >40 years than in those aged <30 years at the carotid bifurcation (0.76 (0.25) v 0.55 (0.06), p = 0.0007) and internal carotid artery (0.63 (0.25) v 0.45 (0.09), p = 0.02); no differences were seen in the younger age group compared with controls.
CONCLUSION: Atherosclerosis is a possibility in patients with PAPS in their fourth decade of life or older.

Entities:  

Mesh:

Year:  2004        PMID: 15155372      PMCID: PMC1755368          DOI: 10.1136/ard.2004.023952

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Authors:  Erick Alexanderson; Patricio Cruz; Angélica Vargas; Aloha Meave; Alejandro Ricalde; Jose A Talayero; José Luis Romero-Ibarra; Tovë M Goldson; Olga L Vera-Lastra; Gabriela Medina; Luis Jara; Mary-Carmen Amigo
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

3.  Dyslipidemia and its relationship with antiphospholipid antibodies in APS patients in North Kerala.

Authors:  Shajit Sadanand; Binoy J Paul; Emil J Thachil; Rejadheesh Meletath
Journal:  Eur J Rheumatol       Date:  2016-12-01

4.  Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels.

Authors:  Jovica Saponjski; Ljudmila Stojanovich; Jelena Saponjski; Milorad Mirilovic; Dusan Saponjski
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

5.  Accelerated atherosclerosis in SLE: mechanisms and prevention approaches.

Authors:  Ashley J Wilhelm; Amy S Major
Journal:  Int J Clin Rheumtol       Date:  2012-10-01

6.  Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Authors:  Victoria Ulrich; Eddy S Konaniah; Wan-Ru Lee; Sadiksha Khadka; Yu-Min Shen; Joachim Herz; Jane E Salmon; David Y Hui; Philip W Shaul; Chieko Mineo
Journal:  J Am Heart Assoc       Date:  2014-10-14       Impact factor: 5.501

Review 7.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

8.  8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study.

Authors:  Savino Sciascia; Dario Roccatello; Maria Tiziana Bertero; Debora Di Simone; Domenico Cosseddu; Antonella Vaccarino; Mario Bazzan; Daniela Rossi; Cesar Garcia-Fernandez; Leticia Ceberio; Stefania Stella; Elisa Menegatti; Simone Baldovino
Journal:  Inflamm Res       Date:  2012-05-26       Impact factor: 4.575

Review 9.  Atherosclerosis in autoimmune diseases.

Authors:  Eiji Matsuura; Kazuko Kobayashi; Luis R Lopez
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 10.  Systemic antiphospholipid syndrome and atherosclerosis.

Authors:  Luis J Jara; Gabriela Medina; Olga Vera-Lastra
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.